Abstract
Natural killer (NK) cells circulate through the blood, lymphatics and tissues, on patrol for the presence of transformed or pathogen-infected cells. As almost all NK cell receptors bind to host-encoded ligands, signals are constantly being transmitted into NK cells, whether they interact with normal or abnormal cells. The sophisticated repertoire of activating and inhibitory receptors that has evolved to regulate NK cell activity ensures that NK cells protect hosts against pathogens, yet prevents deleterious NK cell–driven autoimmune responses. Here I highlight recent advances in our understanding of the structural properties and signaling pathways of the inhibitory and activating NK cell receptors, with a particular focus on the ITAM-dependent activating receptors, the NKG2D-DAP10 receptor complexes and the CD244 receptor system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kärre, K., Ljunggren, H.G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319, 675–678 (1986).
Ravetch, J.V. & Lanier, L.L. Immune inhibitory receptors. Science 290, 84–89 (2000).
Tessmer, M.S. et al. KLRG1 binds cadherins and preferentially associates with SHIP-1. Int. Immunol. 19, 391–400 (2007).
Stebbins, C.C. et al. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell. Biol. 23, 6291–6299 (2003).
Alvarez-Arias, D.A. & Campbell, K.S. Protein kinase C regulates expression and function of inhibitory killer cell Ig-like receptors in NK cells. J. Immunol. 179, 5281–5290 (2007).
Bryceson, Y.T., March, M.E., Ljunggren, H.G. & Long, E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107, 159–166 (2005).
Feng, J., Garrity, D., Call, M.E., Moffett, H. & Wucherpfennig, K.W. Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors. Immunity 22, 427–438 (2005).
Lanier, L.L., Yu, G. & Phillips, J.H. Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342, 803–805 (1989).
Lanier, L.L., Yu, G. & Phillips, J.H. Analysis of FcγRIII (CD16) membrane expression and association with CD3ζ and FcɛRI-γ by site-directed mutation. J. Immunol. 146, 1571–1576 (1991).
McVicar, D.W. et al. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J. Biol. Chem. 273, 32934–32942 (1998).
Colucci, F. et al. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat. Immunol. 3, 288–294 (2002).
Chiesa, S. et al. Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107, 2364–2372 (2006).
Hesslein, D.G., Takaki, R., Hermiston, M.L., Weiss, A. & Lanier, L.L. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc. Natl. Acad. Sci. USA 103, 7012–7017 (2006).
Mason, L.H., Willette-Brown, J., Taylor, L.S. & McVicar, D.W. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J. Immunol. 176, 6615–6623 (2006).
Huntington, N.D., Xu, Y., Nutt, S.L. & Tarlinton, D.M. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary NK cells. J. Exp. Med. 201, 1421–1433 (2005).
Tassi, I. et al. Phospholipase C-γ2 Is a critical signaling mediator for murine NK cell activating receptors. J. Immunol. 175, 749–754 (2005).
Cella, M. et al. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J. Exp. Med. 200, 817–823 (2004).
Ting, A.T., Karnitz, L.M., Schoon, R.A., Abraham, R.T. & Leibson, P.J. Fcγ receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-γ1 and PLC-γ2 in natural killer cells. J. Exp. Med. 176, 1751–1755 (1992).
Billadeau, D.D. et al. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Exp. Med. 188, 549–559 (1998).
Paolini, R., Molfetta, R., Piccoli, M., Frati, L. & Santoni, A. Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement. Proc. Natl. Acad. Sci. USA 98, 9611–9616 (2001).
Galandrini, R. et al. SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells. Blood 100, 4581–4589 (2002).
Houchins, J.P., Yabe, T., McSherry, C. & Bach, F.H. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173, 1017–1020 (1991).
Bauer, S. et al. Activation of natural killer cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727–730 (1999).
Jamieson, A.M. et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17, 19–29 (2002).
Wu, J. et al. An activating receptor complex on natural killer and T cells formed by NKG2D and DAP10. Science 285, 730–732 (1999).
Diefenbach, A. et al. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3, 1142–1149 (2002).
Gilfillan, S., Ho, E.L., Cella, M., Yokoyama, W.M. & Colonna, M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3, 1150–1155 (2002).
Rosen, D.B. et al. A structural basis for the association of DAP12 with mouse, but not human, NKG2D. J. Immunol. 173, 2470–2478 (2004).
Andre, P. et al. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. Eur. J. Immunol. 34, 961–971 (2004).
Garrity, D., Call, M.E., Feng, J. & Wucherpfennig, K.W. The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. Proc. Natl. Acad. Sci. USA 102, 7641–7646 (2005).
Wu, J., Cherwinski, H., Spies, T., Phillips, J.H. & Lanier, L.L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192, 1059–1068 (2000).
Upshaw, J.L. et al. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat. Immunol. 7, 524–532 (2006).
Billadeau, D.D., Upshaw, J.L., Schoon, R.A., Dick, C.J. & Leibson, P.J. NKG2D–DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway. Nat. Immunol. 4, 557–564 (2003).
Graham, D.B. et al. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics. J. Immunol. 177, 2349–2355 (2006).
Giurisato, E. et al. Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse. Mol. Cell. Biol. 27, 8583–8599 (2007).
Zompi, S. et al. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat. Immunol. 4, 565–572 (2003).
Horng, T., Bezbradica, J.S. & Medzhitov, R. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat. Immunol. 8, 1345–1352 (2007).
Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357–366 (2004).
Sutherland, C.L. et al. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J. Immunol. 168, 671–679 (2002).
Kubin, M. et al. ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur. J. Immunol. 31, 1428–1437 (2001).
Ehrlich, L.I.R. et al. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells. J. Immunol. 174, 1922–1931 (2005).
Verneris, M.R., Karami, M., Baker, J., Jayaswal, A. & Negrin, R.S. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. Blood 103, 3065–3072 (2004).
Ma, C.S., Nichols, K.E. & Tangye, S.G. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu. Rev. Immunol. 25, 337–379 (2007).
Veillette, A. NK cell regulation by SLAM family receptors and SAP-related adapters. Immunol. Rev. 214, 22–34 (2006).
Veillette, A., Dong, Z. & Latour, S. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes. Immunity 27, 698–710 (2007).
Valiante, N.M. & Trinchieri, G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178, 1397–1406 (1993).
Tangye, S.G. et al. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 162, 6981–6985 (1999).
Bottino, C. et al. NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus–infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194, 235–246 (2001).
Bouchon, A., Cella, M., Grierson, H.L., Cohen, J.I. & Colonna, M. Cutting edge: activation of NK cell-mediated cytotoxicity by a SAP- independent receptor of the CD2 family. J. Immunol. 167, 5517–5521 (2001).
Mathew, P.A. et al. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J. Immunol. 151, 5328–5337 (1993).
Garni-Wagner, B.A., Purohit, A., Mathew, P.A., Bennett, M. & Kumar, K. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J. Immunol. 151, 60–70 (1993).
Schatzle, J.D. et al. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc. Natl. Acad. Sci. USA 96, 3870–3875 (1999).
Chen, R., Latour, S., Shi, X. & Veillette, A. Association between SAP and FynT: inducible SH3 domain-mediated interaction controlled by engagement of the SLAM receptor. Mol. Cell. Biol. 26, 5559–5568 (2006).
Roncagalli, R. et al. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nat. Immunol. 6, 1002–1010 (2005).
Calpe, S. et al. Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters. Immunogenetics 58, 15–25 (2006).
Clarkson, N.G., Simmonds, S.J., Puklavec, M.J. & Brown, M.H. Direct and indirect interactions of the cytoplasmic region of CD244 (2B4) in mice and humans with FYN kinase. J. Biol. Chem. 282, 25385–25394 (2007).
Tangye, S.G., Phillips, J.H., Lanier, L.L. & Nichols, K.E. Cutting edge: functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165, 2932–2936 (2000).
Nakajima, H. et al. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30, 3309–3318 (2000).
Parolini, S. et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192, 337–346 (2000).
Bloch-Queyrat, C. et al. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J. Exp. Med. 202, 181–192 (2005).
Lee, K.M. et al. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J. Exp. Med. 199, 1245–1254 (2004).
Vaidya, S.V. et al. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. J. Immunol. 174, 800–807 (2005).
Taniguchi, R.T., Guzior, D. & Kumar, V. 2B4 inhibits NK cell fratricide. Blood 110, 2020–2023 (2007).
Lee, K.M. et al. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood 107, 3181–3188 (2006).
Tangye, S.G., Cherwinski, H., Lanier, L.L. & Phillips, J.H. 2B4-mediated activation of human natural killer cells. Mol. Immunol. 37, 493–501 (2000).
Eissmann, P. et al. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105, 4722–4729 (2005).
Chen, R. et al. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors. Mol. Cell. Biol. 24, 5144–5156 (2004).
Watzl, C., Stebbins, C.C. & Long, E.O. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165, 3545–3548 (2000).
Saborit-Villarroya, I. et al. The adaptor protein 3BP2 binds human CD244 and links this receptor to Vav signaling, ERK activation, and NK cell killing. J. Immunol. 175, 4226–4235 (2005).
Aoukaty, A. & Tan, R. Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease. J. Immunol. 174, 4551–4558 (2005).
Chuang, S.S., Kumaresan, P.R. & Mathew, P.A. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways. J. Immunol. 167, 6210–6216 (2001).
Aoukaty, A. & Tan, R. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. J. Biol. Chem. 277, 13331–13337 (2002).
Klem, J., Verrett, P.C., Kumar, V. & Schatzle, J.D. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J. Immunol. 169, 55–62 (2002).
Bottino, C. et al. Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells. Eur. J. Immunol. 30, 3718–3722 (2000).
Watzl, C. & Long, E.O. Natural killer cell inhibitory receptors block actin cytoskeletal-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med. 197, 77–85 (2003).
Wahle, J.A. et al. Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets. J. Immunol. 176, 7165–7169 (2006).
Wahle, J.A. et al. Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell. J. Immunol. 179, 8009–8015 (2007).
Bhat, R. & Watzl, C. Serial killing of tumor cells by human natural killer cells – enhancement by therapeutic antibodies. PLoS ONE 2, e326 (2007).
Acknowledgements
I thank D. Billadeau, A. Weiss, J. Djeu, J. Carlyle, C. Chang, J. Orange, S. Tangye and N. Bezman for discussions and help with the illustrations. Supported by the US National Institutes of Health (AI066897, AI068129, CA095137, CA105379 and AI64520) and the American Cancer Society. Dedicated to the memory of my friend Paul Leibson who made significant contributions to our understanding of NK cell receptor signaling.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The University of California San Francisco has licensed intellectual property rights relating to NKG2D for potential therapeutic development.
Supplementary information
Supplementary Text and Figures
Supplementary Table 1 and Supplementary Table 2 (PDF 79 kb)
Rights and permissions
About this article
Cite this article
Lanier, L. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9, 495–502 (2008). https://doi.org/10.1038/ni1581
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1581
This article is cited by
-
Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity
The EMBO Journal (2024)
-
CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma
Journal of Experimental & Clinical Cancer Research (2023)
-
25KDa branched polyethylenimine increases interferon-γ production in natural killer cells via improving translation efficiency
Cell Communication and Signaling (2023)
-
GPR116 receptor regulates the antitumor function of NK cells via Gαq/HIF1α/NF-κB signaling pathway as a potential immune checkpoint
Cell & Bioscience (2023)
-
hMSCs treatment attenuates murine herpesvirus-68 (MHV-68) pneumonia through altering innate immune response via ROS/NLRP3 signaling pathway
Molecular Biomedicine (2023)